Large-scale exome sequencing of tumors has enabled the identification of cancer drivers using 37 recurrence and clustering-based approaches. Some of these methods also employ three-38 dimensional protein structures to identify mutational hotspots in cancer-associated genes. In 39 determining such mutational clusters in structures, existing approaches overlook protein 40 dynamics, despite the essential role of dynamics in protein functionality. In this work, we present 41 a framework to identify driver genes using a dynamics-based search of mutational hotspot 42 communities. After partitioning 3D structures into distinct communities of residues using 43 anisotropic network models, we map variants onto the partitioned structures. We then search for 44 signals of positive selection among these residue communities to identify putative drivers. We 45 applied our method using the TCGA pan-cancer atlas missense mutation catalog. Overall, our 46 analyses predict one or more mutational hotspots within the resolved structures of 434 genes. 47
identify significantly mutated genes and non-coding genomic elements [8] [9] [10] [11] . However, the somatic 77 mutation landscapes of cancer genomes are highly heterogeneous [12] [13] [14] and exhibit a long tail of 78 low-frequency mutations 11, 13, [15] [16] [17] . The presence of this long tail of rare somatic mutations, along 79 with limited cohort sizes, makes recurrence-based driver identification very challenging. An 80 alternative is to employ algorithms that aggregate mutation recurrence on gene/element-81 levels 18, 19 or to predict the molecular functional impact of mutations 20 to distinguish drivers from 82 passengers. Compared to protein-truncating mutations and large structural variants, missense 83 mutations induce subtle changes, which are often difficult to interpret on the phenotypic level. 84
Thus, identifying missense driver mutations based on their molecular functional impact is also 85 challenging. In contrast, the signal of positive selection aggregated on functional elements or 86 sub-regions of the coding genome (such as protein domains [21] [22] [23] , post-translational modification 87 sites (PTMS) [24] [25] [26] , protein interaction interfaces 27,28 and mutation cluster/hotspots [29] [30] [31] ) has been 88 shown to be effective, despite their intrinsic limitations. 89
90
Prior studies have identified driver mutations based on their presence in mutational clusters [29] [30] [31] , 91 which are sometimes called "hotspot" regions. These mutational clusters are defined based on 92 the proximity of somatic mutations within the primary sequence 29, 31 or three-dimensional 93 structure of a given protein [32] [33] [34] [35] [36] . Sequence-based mutation cluster identification algorithms 29, 31, 37 94 discover significantly mutated genes while considering an appropriate background mutation 95 model, trinucleotide context of mutations and distribution of silent mutations. However, 96 sequence-based approaches miss many hotspot regions, as they ignore spatial proximity between 97 residues that may be far apart in sequence but can be very close in 3-dimensional(3D) space 38, 39 , 98 in the context of the fully-folded protein or protein ensembles. In contrast, despite being 99 inherently limited due to incomplete structural coverage of the proteome, 3D structure-based 100 mutational cluster definitions provide physical intuition or mechanistic insight into the roles of a 101 mutational cluster in cancer progression [32] [33] [34] [35] [36] . These structure-based methods compute residue 102 distances or generate residue-residue contact networks in the 3D structures of proteins to identify 103 a group of spatially proximal residues. Furthermore, mutation shuffling is performed to identify 104 significantly mutated residue clusters or hotspots on a protein structure. As discussed above, our framework to predict driver genes through identification of hotspot 175 communities is novel compared to prior approaches as we explicitly include protein dynamics 176 information in our workflow (Fig 1) . Briefly, our integrative workflow includes three distinct 177 components. First, we model large-scale conformational changes of a protein to identify dynamic 178 sub-regions of proteins (or "communities"). The large-scale conformational changes are modeled 179 using anisotropic network models (ANMs) 46, 55 . Subsequently, we model protein structure as a 180 residue-interaction network, where each residue constitutes a node in the network, and edges (or 181 connections between these nodes) form the physical interactions between these nodes. 182
Furthermore, edges in a network can be 'weighted' using the extent to which contacting residues 183 exhibit correlated movements within the dynamic structure of the protein. significance test assigns an empirical p-value, which we correct for multiple hypothesis testing 203 using the Benjamini Hochberg method to identify significantly mutated hotspot communities on 204 protein structure for a given gene. We note that, for a substantial number of genes, there are 205 multiple PDB structures available. We remove this structural redundancy using structural 206 coverage (highest fraction of residues covered in the structure) as a filter to provide one to one 207 mapping between PDB structure and corresponding gene. The source code for the workflow is 208 available on the project's Github page (https://github.com/gersteinlab/HotComms). 209 210 211
Downstream Analyses 212
We performed many downstream analyses to further validate our predictions. We extracted 213 PhyloP 57 and CADD 58 score for each mutation mapping onto protein structures. Furthermore, we 214 classified mutations into hotspot and non-hotspot mutations based on whether mutations are 215 mapped onto residues belonging to hotspot communities or otherwise. Subsequently, we 216 compared the phyloP score and CADD score distributions for hotspot and non-hotspot 217 mutations. We performed two-sided Kolmogorov-Smirnov(KS) test to assess the significance of 218 conservation score differences between hotspot and non-hotspot mutations. We apply the samemethod to quantify such disparities for the molecular functional impact (CADD) score for 220 hotspot and non-hotspot mutations. Here, our null hypothesis is that the conservation or impact 221 score for hotspot and non-hotspot mutations are on average not different as they are being drawn 222 from the same distribution. 223
224
We also performed gene ontology(GO) enrichment and pathway enrichment analyses to further 225 validate the role of our putative driver genes in tumor progression. For the GO analysis, we 226 calculated the enrichment based on biological processes available from the GO database 59 , and 227
we performed pathway enrichment analysis using the Reactome 60 as well as the KEGG 228 database 61 . We visualized the enrichment analysis result using the clusterProfiler 62 package 229 available in Bioconductor. 230 231 Additionally, we also compared our predicted driver gene list derived from our hotspot 232 community analysis with other approaches that detect driver genes based on the presence of 233 mutation clusters on sequence or structure levels. One of the key differences between our 234 approach and other approaches is that we employ information on protein dynamics (along with 235 structural data) to determine hotspot communities. For structure-based methods, we obtained 236 driver gene list predicted from HotSpot3D 35 , 3DHotSpot 34 , HotMap 36 algorithms. All three of 237 these algorithms were previously applied on the TCGA Pancan Atlas data 5 , which allows us to 238 make meaningful comparisons with our work. However, we also note small differences in our 239 workflow compared to other structure-based approaches. For instance, HotMap tools employ 240 homology-model derived structures compared to other methods that rely only of experimentally 241 determined structure. Moreover, our method was applied only on crystal structure at higher 242 resolution compared to other methods that included NMR as well as crystal structures at higher 243 resolution. Finally, we also employed predicted driver genes from sequence-based cluster 244 analysis tool (OncodriverClust 31 ) and previously curated driver genes in the cancer gene 245 census(CGC) database 63, 64 . We note that we excluded driver genes in CGC that play role in 246 cancer through INDELs, copy number aberrations or other structural variations. We used 247 
Pan-cancer analysis of genes containing mutations clusters 263
We applied our workflow to identify significantly mutated hotspot communities for each cancer 264 cohort as well as on the pan-cancer level. As expected, we observed a comparatively higher 265 number of genes with at least one hotspot community on the pan-cancer level compared to 266 cancer-specific analysis. Our pan-cancer analysis identifies hotspot communities present on 267 protein structures of 434 unique genes (Fig 2a, supplement table S1 ). In contrast, a cancer-268 specific analysis revealed 56 potential driver genes with 186 significantly mutated hotspot 269 community in the corresponding protein structure (Supplement table S2). Some of these genes 270 (including TP53, PIK3CA, BRAF, SPOP, KRAS, HRAS, and PTEN) have been previously 271 shown to be a driver for different cancer types. However, we also identified numerous novel 272 genes containing hotspot communities that might drive cancer progression. Previous studies 273 suggest that some of these novel genes including RHOC, NCOA1, and KLHL12 are involved in 274 various signaling pathways. Similarly, PSPC1, FOXO3, and XRCC5 are known to be pivotal for 275 immune response, apoptosis, and DNA repair, respectively. Furthermore, among these 434 276 genes, 12 genes had five or more hotspot communities whereas 352 genes had just one hotspot 277 community on their corresponding protein structure. These observations highlight the efficacy of 278 our approach in identifying novel and low-frequency putative driver genes with hotspot 279 communities. 280
Mutation cluster-based approaches assume that residues constituting such clusters are essential 282 for protein functions. Thus, a majority of cancer missense mutations occupying these hotspot 283 communities are very likely to disrupt the protein function. In order to validate this assumption, 284 we quantified the cross-species conservation measure (PhyloP score 57 ) for mutations in hotspot 285 as well as non-hotspot communities on protein structures. As expected, we observe higher 286 average conservation score for mutations mapping to residues in hotspot communities compared 287 to those, which are present outside. Furthermore, the observed difference in conservation is 288 statically significant (two-sided KS test, p-value < 2e-5) (Fig 2b) . Similarly, the putative 289 molecular functional impact (CADD score 58 ) of mutations occupying hotspot communities was 290 significantly higher compared to those mapping to non-hotspot communities (two-sided KS test, 291 p-value < 2e-5) (Fig 2c) . 292
293
We also preformed gene ontology 62 and pathway enrichment analysis to decipher the biological 294 function of genes with predicted hotspot communities. The biological process based gene 295 ontology enrichment analysis indicate role of putative driver genes in diverse biological function 296 including immune response, cell differentiation, kinase activities, post-translational 297 modifications, apoptosis and DNA repair (Fig 2d & Supplement table S3) . Similarly, reactome 298 pathway 60 based enrichment analysis suggest role of putative driver genes with hotspot 299 communities in various signaling pathways (Supplement table S4) including NTRK signaling, 300 DAP12 signaling, EGFR signaling and MAP kinase-associated signaling. Additionally, these 301 genes are also enriched among DNA repair and non-homologous end-joining associated 302 pathways (Fig 2e) We performed consensus analysis between our approach to the driver genes curated in the 308 COSMIC 67 database. Furthermore, we also performed a comparison between putative driver 309 genes identified using our workflow and genes identified as drivers by other mutation cluster 310 detection algorithms that do not take protein dynamics into account. The majority of these 311 additional algorithms employ the three-dimensional structure of a protein to identify mutational 312 cluster except the OncoDriveClust 31 tool, which searches for hotspot mutations on the sequence 313 level. Overall, our workflow identified many additional genes (288 genes) with hotspot 314 communities compared to other mutation hotspot analysis tools (Fig 3a) . One exception being 315 the HOTMAP 36 algorithm that utilizes protein homology model in addition to protein structure. 316
Thus, it identifies significantly higher number of unique genes (620 genes) with mutation cluster 317 compared to any other tool. Furthermore, our approach identified 146 genes (34% of our gene 318 list) with hotspot communities that are either curated as a driver gene in COSMIC or predicted to 319 contain a mutation cluster by another tool (Fig 3a) . Among these 146 genes, 89 genes 320 overlapped with putative driver genes identified by HOTMAP algorithm, whereas 63 genes 321 overlapped with drivers in COSMIC. As expected, we observed the lowest overlap (33 genes, 322 7% of our putative driver gene list) with sequence-based method (OncoDriveClust; Fig 3a) . 323 324 Additionally, we analyzed TCGA expression data to obtain additional evidence corroborating the 325 biological validity of putative driver genes identified through our workflow. Intuitively, one 326 would expect a significant difference in gene expression level between samples with and without 327 mutation for genes that were predicted to contain a significantly mutated hotspot community. For 328 each candidate gene, we quantified the statistical significance in expression distribution 329 differences using two-sided KS test. Furthermore, we performed this test for individual cancer 330 type, and the corresponding p-values were combined across cancer types using Fisher's method 331 to provide a pan-cancer significance measure. Overall, our analysis identified 60 genes including 332 TP53(p-value 3.59e-66), SPTA1 (p-value 8.58e-32), PIK3CA (p-value 7.06e-25), KRAS (p-333 value 5.73e-11), and EGFR (p-value 2.78e-06) that were differentially expressed across cancer 334 types (Fig 3b & Supplement table S6) . A subset of these differentially expressed genes such as 335 MYH7 (p-value 4.22e-15), ROS1 (p-value 3.26e-13), TIAM1 (p-value 2.48e-12), PTPRD (p-336 value 3.96e-23), and HUWE1 (p-value 4.84e-10) are potentially novel driver genes with 337 predicted hotspot communities (Fig 3b & Supplement table S6) . Moreover, we note that 76% 338 of our putative driver gene list with significantly mutated hotspot communities were 339 differentially expressed in at least one TCGA cancer cohort. 340 341 Finally, we performed GO and pathway enrichment analysis on novel genes that we predict to 342 contain mutational hotspot communities. However, these genes were neither present in the 343 COSMIC driver database nor were predicted to encompass mutation cluster through other 344 hotspot identification tools. We observed significant enrichment of these genes in crucial 345 biological processes (Supplement table S7) including DNA conformation change, regulation of 346 immune response, regulation of stem cell differentiation, nucleosome organization, and 347 endothelial cell apoptotic process (Supplement Fig2) . Similarly, pathway enrichment analysis 348 implicates their role in DNA repair, SUMOylation, RHO GTPase activity, telomere 349 maintenance, and various signaling pathways (Fig 3c & Supplement table S8) . distinct domains belonging to the catalytic P110 alpha subunit that harbor somatic mutations 376 leading to an increase in PI3K activity. We observe two distinct hotspot communities (Fig 4a) on 377 the co-crystal structure (PDB ID: 2V1Y) of the protein complex that compromises ABD domain 378 of the P110 alpha subunit and the iSH2 domain of the p85 alpha regulatory subunit. The two 379 hotspot communities are composed of 28(community 5) and 26(community 7) residues, 380 respectively (Fig 4a) . On the pan-cancer level, we observe 24 and 16 mutations that map to 381 community 5 and community7 on the co-crystal structure, respectively. These distinct hotspot 382 communities are adjacent to each other in the same helical structure. However, we observe a 383 small kink in this helical structure, which presumably lead to distinct protein motions associated 384 with these two different hotspot communities. 590885 has been co-crystallized with BRafV600E kinase domain at the X-ray resolution of 2.9 397 Angstrom (PDBID: 2FB8) 70 . A previous study indicates the role of pi-stacking interactions, 398 hydrogen bonds and salt bridges in stabilizing the interaction between these two subunits in the 399 crystal structure. In our study, we identified one hotspot community in this co-crystal structure 400 (Fig 4b) . This hotspot community is composed of 52 residues that constitute a beta sheet 401 secondary structure. Interestingly, we also observe that SB-590885 inhibitor occupies the same 402 hotspot community. 403
404

Missense hotspot community in TPRD gene 405
The PTPRD gene encodes a protein that belongs to the protein tyrosine phosphatase(PTP) 406 family. PTP proteins are considered essential for regulating cellular proliferation, differentiation, 407 and oncogenic transformation. PTPRD gene encodes a transmembrane protein containing a 408 cytoplasmic tyrosine phosphatase domain. Previous studies have shown that PTPRD genes are 409 frequently deleted in various cancer types including glioma, neuroblastoma, and lung cancer 71 . 410
However, we note PTPRD is not identified as missense driver in cosmic catalog. Moreover, 411 previous studies did not identify presence of mutational hotspot communities in the PTPRD 412 gene. In contrast, our analysis identifies one hotspot community in the crystal structure (PDB ID: 413 2YD7) of the receptor protein tyrosine phosphatase(RPTP) sigma subunit. RPTPs are cell 414 surface proteins with intracellular PTP activity and extracellular domains that are sequentially 415 homologous to cell adhesion molecules. Moreover, RPTP sigma subunit is considered necessary 416 for nervous system development and function. In our analysis, somatic mutations mapped to two 417 communities (community 2 & 4) on the crystal structure of the RPTP sigma subunit. Our 418 workflow predicts one hotspot community that comprise of 47 residues in the crystal structure of 419 PTPRD (Fig 4c) and adopts a beta strand conformation. cancer genome provides limited power to identify low-frequency drivers using the canonical 430 position level recurrence algorithms. A simplistic approach to address the issue of missing rare 431 driver will be to sequence more patients for a given cancer type. However, this approach will be 432 particularly challenging for highly heterogeneous cancer cohorts with multiple subtypes 73 within 433 a cancer type. Moreover, this approach will not be practical for certain rare cancers including 434 neuroblastoma, angiosarcoma, Hodgkin's lymphoma, and others. A suitable alternative is to 435 quantify recurrence over functional elements or sub-gene levels 74 such as post-translational 436 modification sites (PTMS) 25, 26 , protein interaction interfaces 28 and mutational clusters [33] [34] [35] [36] 38 . In 437 particular, many driver detection algorithms search for the presence of mutational hotspot on the 438 3D-protein structures to identify putative driver genes. Compared to sequence-based driver 439 detection methods, using protein structural data can help to decipher the underlying molecular 440 mechanisms that influence cancer progression. However, current approaches to identify cancer 441 mutation hotspots on protein structure and corresponding driver genes completely ignore the role 442 of protein dynamics, which is considered essential for protein function. Thus, here we propose a 443 new framework that utilizes protein dynamics along with the 3D-structure of proteins to identify 444 missense hotspot communities on protein structure and corresponding putative driver genes. 445 446 Overall, our workflow identified 802 hotspot communities on crystal structures of proteins 447 corresponding to 434 unique genes on the pan-cancer level. We also compared our putative 448 driver gene list with previous experimental and prediction studies derived driver gene list. 449
Among our putative driver gene list, we find 36% of genes are either known or predicted to be 450 driver genes based on previous studies. We term the remaining 64% of genes as novel drivers in 451 our study. We performed many downstream analyses on our putative driver genes to highlight 452 their role in cancer progression. Our framework assumes that a residue community on a protein 453 structure represents a putative functional subunit of a protein. Thus, high mutation densities in 454 such communities (compared to a random expectation) is very likely to alter protein function. 455
One would expect that mutations influencing residues in these communities will have a high 456 functional impact as they can drive cancer progression. Our observation is consistent with this 457 hypothesis, as we find that missense mutations occupying hotspot communities in proteins 458 structures are highly conserved across species and have a higher molecular functional impact 459 compared to those outside such hotspot communities. transcriptome level such that mutated driver genes are often differentially expressed compared to 483 a healthy population or patients without any mutation in driver genes. We leveraged the 484 transcriptome data from TCGA to further validate out predicted driver genes based on hotspot 485 community identification. We identified 60 genes among our predicted driver genes that were 486 significantly differentially expressed in tumor samples with missense mutations in those genes 487 compared to those without among multiple cancer cohorts. These differentially expressed driver 488 genes include novel as well previously established driver genes. Similar to genetic data, 489 transcriptomic data in TCGA is limited for specific cancer cohort that provides insufficient 490 power to identify all differentially expressed genes. However, we note that 76% of our putative 491 driver genes were differentially expressed in at least one TCGA cancer cohort. These analyses 492 further validate our hotspot community-based driver detection approach. 493
494
In the context of investigating the molecular mechanism underlying tumor growth, protein 495 structure-based driver detection methods offer significant advantages over approaches that are 496 only sequence-based. However, structure-based methods suffer from limited coverage of the 497 human proteome. Thus, the applicability of structure-based methods is inherently limited only tomutations that can be mapped onto protein structure. A prior study 36 has applied homology 499 model derived structures to circumvent the issue of limited structural coverage. However, the 500 accuracy of homology-based models has shown to be limited for various protein complexes and 501 transmembrane proteins. Moreover, modeling protein motions for homology-model derived 502 proteins structures will be most likely less accurate thus affecting the sensitivity of our approach. 503
Nevertheless, significant technical improvement in crystallographic and cryoEM techniques 75 are 504 expected to expand the current structurally-resolved proteome. In particular, cryoEM 505 technologies 75 now allows us to obtain a high-resolution structure of large-size proteins and other 506 biomolecular complexes that were previously elusive. Thus, we anticipate an essential role of our 507 approach in future studies aimed at discovering low-frequency drivers in various cancer cohorts. for putative driver genes with at least one hotspot. X-axis corresponds to gene ratio that 561 corresponds to the fraction of putative driver genes belonging to a particular biological process. 562
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